In 2023, Spain led European hospital discharges for diseases of the skin and subcutaneous tissue with a share of 30.57. The Czech Republic and Austria followed with 12.75 and 12.05, respectively. Belgium and Norway showed positive year-on-year variations, with Belgium at 1.98% and Norway at 2.96%. However, Austria, Slovakia, the Netherlands, Finland, and Slovenia saw declines, with Finland experiencing the steepest drop at -3.45%. Over the last five years, the compound annual growth rate (CAGR) indicated varied growth rates, reflecting a dynamic market environment.
Future trends to watch include the increasing adaptation of telemedicine and the integration of digital health tools, which could influence hospital discharge dynamics. Additionally, demographic changes and advances in dermatological treatments may lead to shifts in discharge patterns across Europe.
Top countries in Hospital Discharges for Diseases of the Skin and Subcutaneous Tissue Share by Country (Units (Hospital Discharges))
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Spain | 30.57 | 2023 | +5.97% | +0.61% | View data |
| 2 | 2 Czech Republic | 12.75 | 2023 | +4.46% | +0.58% | View data |
| 3 | 3 Austria | 12.05 | 2023 | +1.77% | -1.57% | View data |
| 4 | 4 Belgium | 10.24 | 2023 | +9.32% | +1.98% | View data |
| 5 | 5 Slovakia | 7.94 | 2023 | +6.31% | -0.64% | View data |
| 6 | 6 Netherlands | 7.17 | 2023 | +2.38% | -0.54% | View data |
| 7 | 7 Norway | 5.97 | 2023 | +7.3% | +2.96% | View data |
| 8 | 8 Portugal | 4.48 | 2021 | +10.36% | View data | |
| 9 | 9 Finland | 4.04 | 2023 | -1.92% | -3.45% | View data |
| 10 | 10 Slovenia | 2.12 | 2023 | +4.57% | -0.5% | View data |
